Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecurityRXI / iShares S&P Global Consumer Discretionary Sector Index Fund (464288745)
Institutional Owners65
Institutional Shares1,546,290
Institutional Value$ 176,197,000 USD
Related IFXAF / Ishare FTSE/Xinhua A50 China Tracker (Hong Kong)
IOO / iShares Global 100 ETF
IXC / iShares Global Energy ETF
IXG / iShares Global Financials ETF
IGF / iShares Global Infrastructure ETF
JKH / iShares Morningstar Mid Growth Index Fund
EFG / iShares MSCI EAFE Growth ETF
EFV / iShares MSCI EAFE Value Index
EPOL / iShares MSCI Poland Capped ETF
SUSA / iShares MSCI USA ESG Select ETF
IWL / iShares Russell Top 200 Index Fund
IWX / iShares Russell Top 200 Value Index Fund
SUB / iShares Short-Term National Muni Bond ETF
KXI / iShares S&P Global Consumer Staples Sector Index Fund
EXI / iShares S&P Global Industrials Sector Index Fund
MXI / iShares S&P Global Materials Sector Index Fund
JXI / iShares S&P Global Utilities Sector Index Fund
IGE / iShares S&P North American Natural Resources Sector Index Fund
GLJ / iShares Trust
FALN / iShares Trust iShares Fallen Angels USD Bond ETF
HYXE / iShares Trust iShares iBoxx $ High Yield ex Oil & Gas Corporate Bond ETF
ESGD / iShares Trust iShares MSCI EAFE ESG Optimized ETF
MPCT / iShares Trust iShares MSCI Global Impact ETF

Institutional Stock Ownership and Shareholders()

iShares S&P Global Consumer Discretionary Sector Index Fund (NYSE:RXI) has 65 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,546,290 shares. Largest shareholders include NN Investment Partners Holdings N.V., BlackRock Inc., Newfound Research LLC, Commonwealth Equity Services, Inc, Morgan Stanley, Bank Of America Corp /de/, Wilbanks Smith & Thomas Asset Management Llc, Jane Street Group, Llc, TRUE Private Wealth Advisors, and Summit X, Llc.
iShares S&P Global Consumer Discretionary Sector Index Fund (NYSE:RXI) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-15 13F-HR Bb&t Investment Services, Inc. 54 54 0.00 5 6 20.00
2018-07-27 13F-HR/A WHITTIER TRUST CO OF NEVADA INC 1,500 1,500 0.00 167 172 2.99
2018-08-07 13F-HR Kcs Wealth Advisory 7,331 8,162 11.34 817 938 14.81
2018-08-14 13F-HR JP Morgan Chase & Co 75 75 0.00 8 9 12.50
2018-08-13 13F-HR SCOTIA CAPITAL INC. 2,947 3,017 2.38 281 286 1.78
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 59,916 58,541 -2.29 6,680 6,725 0.67
2018-08-13 13F-HR ADVANTAGE INVESTMENT MANAGEMENT, LLC 100 100 0.00 11 11 0.00
2018-08-09 13F-HR BlackRock Inc. 372,823 362,004 -2.90 41,562 41,583 0.05
2018-08-14 13F-HR AMERIPRISE FINANCIAL INC 12,016 11,561 -3.79 1,339 1,328 -0.82
2018-08-06 13F-HR SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 1,100 1,175 6.82 123 135 9.76
2018-08-13 13F-HR Summit X, Llc 25,982 26,680 2.69 2,893 2,845 -1.66
2018-08-14 13F-HR InterOcean Capital, LLC 9,129 9,785 7.19 1,018 1,124 10.41
2018-08-10 13F-HR ENVESTNET ASSET MANAGEMENT INC 9,555 13,093 37.03 1,083 1,504 38.87
2018-07-24 13F-HR Janney Montgomery Scott LLC 1,899 1,822 -4.05 212 209 -1.42
2018-07-27 13F-HR Advisory Services Network, LLC 65 65 0.00 7 8 14.29
2018-08-08 13F-HR Private Capital Group, Llc 379 379 0.00 42 43 2.38
2018-08-08 13F-HR Whitener Capital Management, Inc. 75 0 -100.00 8 0 -100.00
2018-08-07 13F-HR GREENLEAF TRUST 32,550 12,517 -61.55 3,629 1,438 -60.37
2018-08-10 13F-HR FIL Ltd 4,732 6,497 37.30 525 748 42.48
2018-08-14 13F-HR Parallax Volatility Advisers, L.P. 1 1 0.00 0 0
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 0 130 0 15
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 24,891 20,300 -18.44 2,775 2,332 -15.96
2018-08-07 13F-HR TD Capital Management LLC 93 93 0.00 10 11 10.00
2018-08-13 13F-HR Advisor Group, Inc. 1,429 1,685 17.91 159 193 21.38
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 122 315 158.20 14 36 157.14
2018-07-13 13F-HR TRUE Private Wealth Advisors 37,630 37,761 0.35 4,194 4,337 3.41
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 42,356 0 -100.00 4,722 0 -100.00
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 6,411 6,411 0.00 715 715 0.00
2018-08-13 13F-HR MML INVESTORS SERVICES, LLC 2,723 2,961 8.74 304 340 11.84
2018-07-25 13F-HR BESSEMER GROUP INC 2,150 2,150 0.00 240 247 2.92
2018-05-09 13F-HR OPTIMUM INVESTMENT ADVISORS 0 190 0 21
2018-08-13 13F-HR Stratos Wealth Partners, LTD. 225 0 -100.00 25 0 -100.00
2018-08-14 13F-HR Slow Capital, Inc. 23,968 23,875 -0.39 2,672 2,742 2.62
2018-08-14 13F-HR SUMITOMO MITSUI FINANCIAL GROUP, INC. 900 0 -100.00 100 0 -100.00
2018-08-06 13F-HR Brookstone Capital Management 14,058 14,137 0.56 1,567 1,624 3.64
2018-08-10 13F-HR CITIGROUP INC 3,066 3,066 0.00 342 352 2.92
2018-07-13 13F-HR Creative Financial Designs Inc /adv 503 0 -100.00 56 0 -100.00
2018-07-12 13F-HR NN Investment Partners Holdings N.V. 0 426,592 0 49,003
2018-08-02 13F-HR Adviser Investments LLC 38 4
2017-01-13 13F-HR MetLife Securities, Inc 3,831 3,876 1.17 342 350 2.34
2018-08-14 13F-HR UBS Group AG 11,084 10,969 -1.04 1,236 1,260 1.94
2017-02-15 13F-HR OLD MISSION CAPITAL, LLC 2,947 266
2018-08-14 13F-HR ROYAL BANK OF CANADA 16,933 17,339 2.40 1,887 1,992 5.56
2018-07-31 13F-HR Commonwealth Equity Services, Llc. 78,162 9,855 -87.39 8,713 1,132 -87.01
2018-08-14 13F-HR Virtue Capital Management, Llc 226 0 -100.00 26 0 -100.00
2018-05-11 13F-HR CITIGROUP INC 3,066 3,066 0.00 335 342 2.09
2018-08-14 13F-HR QUANTUM CAPITAL MANAGEMENT 3,651 3,719 1.86 407 427 4.91
2018-08-06 13F-HR TORONTO DOMINION BANK 9 1
2018-07-30 13F-HR Raymond James Financial Services Advisors, Inc. 0 12,992 0 1,492
2018-08-02 13F-HR BABSON CAPITAL MANAGEMENT LLC 5,400 9,900 83.33 602 1,137 88.87
2018-07-27 13F-HR/A WHITTIER TRUST CO 1,200 1,200 0.00 134 138 2.99
2018-08-03 13F-HR NOMURA ASSET MANAGEMENT CO LTD 11,200 5,600 -50.00 1,249 643 -48.52
2018-08-14 13F-HR FIFTH THIRD BANCORP 5,029 5,029 0.00 561 578 3.03
2018-08-14 13F-HR HighTower Advisors, LLC 1,832 1,878 2.51 204 216 5.88
2018-08-08 13F-HR WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 0 41,805 0 4,802
2018-07-31 13F-HR Newfound Research LLC 81,453 96,431 18.39 9,080 11,077 21.99
2018-07-31 13F-HR CWM, LLC 100 100 0.00 11 11 0.00
2017-10-26 13F-HR BARING ASSET MANAGEMENT Ltd 11,926 0 -100.00 1,180 0 -100.00
2018-08-14 13F-HR LPL Financial LLC 11,376 11,311 -0.57 1,268 1,299 2.44
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 19,962 6,706 -66.41 2,225 770 -65.39
2018-07-25 13F-HR Transamerica Financial Advisors, Inc. 52,117 0 -100.00 5,810 0 -100.00
2018-08-03 13F-HR WRAPMANAGER INC 20,502 19,278 -5.97 2,286 2,214 -3.15
2018-08-06 13F-HR Beaumont Financial Partners, LLC 0 2,084 0 239
2018-08-10 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 138 138 0.00 15 15 0.00
2018-07-12 13F-HR Daiwa SB Investments Ltd. 180 21
2018-08-10 13F-HR Cambridge Investment Research Advisors, Inc. 5,650 2,030 -64.07 630 233 -63.02
2018-08-01 13F-HR Psagot Investment House Ltd. 10,500 9,500 -9.52 1,171 1,091 -6.83
2018-08-08 13F-HR US BANCORP \DE\ 40 40 0.00 4 5 25.00
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 74,287 72,763 -2.05 7,352 7,409 0.78
2018-07-31 13F-HR Front Row Advisors Llc 2,409 2,234 -7.26 269 264 -1.86
2018-08-14 13F-HR MORGAN STANLEY 89,699 70,661 -21.22 10,000 8,117 -18.83
2018-08-09 13F-HR/A Perigon Wealth Management, LLC 1,463 8,924 509.98 163 1,025 528.83
2018-08-15 13F-HR JANE STREET GROUP, LLC 171,807 37,894 -77.94 19,153 4,353 -77.27
2018-08-14 13F-HR Mirae Asset Global Investments Co., Ltd. 19,100 19,100 0.00 2,129 2,194 3.05

Related Articles

REPH: Recro Pharma Analysis and Research Report

12h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

13h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

13h - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 464288745